COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Compugen Ltd
Compugen Ltd
Case Comprehensive Cancer Center
University of Wisconsin, Madison
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
AstraZeneca